Alzheimer amyloid-β peptide forms denaturant-resistant complex with type ε3 but not type ε4 isoform of native apolipoprotein E

Molecular Medicine

Volumn 2, Issue 2, 1996, Pages 175-180

  Zhou, Zhongmin ^a   Smith, Jonathan D ^b   Greengard, Paul ^b   Gandy, Sam ^a  

^a Department of Obstetrics Gynecology   (United States)

^b ROCKEFELLER UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; APOLIPOPROTEIN E;

ALZHEIMER DISEASE; ANIMAL CELL; ARTICLE; GENETIC SUSCEPTIBILITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

EID: 0029754637     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03401614     Document Type: Article

References (35)

1. Strittmatter WJ, Saunders AM, Schmechel D, et al. (1993) Apolipoprotein E: High-avidity binding to β amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 1977-1981.
2. Strittmatter WJ, Weisgraber KH, Huang DY, et al. (1993) Binding of human apolipoprotein E to synthetic amyloid β peptide: Isoform-specific effects and implications for late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 8098-8102.
3. Corder EH, Saunders AM, Strittmatter WJ, et al. (1993) Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science 261: 921-923.
4. Mayeux R, Stern Y, Ottman R, et al. (1993) The apolipoprotein epsilon 4 allele in patients with Alzheimer's disease Ann. Neurol. 34: 752-754.
5. Saunders AM, Strittmatter WJ, Schmechel D, et al. (1993) Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology 43: 1467-1472.
6. Schmechel DE, Saunders AM, Strittmatter WJ, et al. (1993) Increased amyloid β-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease. Proc. Natl. Acad. Sci. U.S.A. 90: 9649-9653.
7. Rebeck GW, Reiter JS, Strickland DK, Hyman BT. (1993) Apolipoprotein E in sporadic Alzheimer's disease: Allelic variation and receptor interactions. Neuron 11: 575-580.
8. Berr C, Hauw JJ, Delaere P, Duyckaerts C, Amouyel P. (1994) Apolipoprotein E allele ε4 is linked to increased deposition of the amyloid β-peptide (A-β) in cases with or without Alzheimer's disease. Neurosci. Lett. 178: 221-224.
9. Polvikoski T, Sulkava R, Haltia M, et al. (1995) Apolipoprotein E, dementia, and cortical deposition of β-amyloid protein. N. Engl. J. Med. 333: 1242-1247.
10. Hyman BT, West HL, Rebeck GW, Lai F, Mann DMA. (1995) Neuropathological changes in Down's syndrome hippocampal formation: Effect of age and apolipoprotein E genotype. Arch. Neurol. 52: 373-378.
11. Greenberg SM, Rebeck GW, Vonsattel JPG, Gomez-Isla T, Hyman BT. (1995) Apolipoprotein E ε4 and cerebral hemorrhage associated with amyloid angiopathy. Ann. Neurol. 38: 254-259.
12. Jordan B, Kanik A, Horwich M, et al. (1995) Apolipoprotein E ε4 and fatal cerebral amyloid angiopathy associated with dementia pugilistica. Ann. Neurol. 38: 698-699.
13. Kalaria RN, Premkumar DRD. (1995) Apolipoprotein E genotype and cerebral amyloid angiopathy. Lancet 346: 1424.
14. St George-Hyslop P, Crapper McLachlan D, Tuda T, et al. (1994) Alzheimer's disease and possible gene interaction. Science 263: 537.
15. Sorbi S, Nacmias B, Forleo P, Piacentini S, Latorraca S, Amaducci L. (1995) Epistatic effect of APP717 mutation and apolipoprotein E genotype in familial Alzheimer's disease. Ann. Neurol. 38: 124-127.
16. Suzuki N, Cheung T, Cai X-D, et al. (1994) An increased percentage of long amyloid β protein secreted by familial amyloid β protein precursor (βAPP717) mutants. Science 264: 1336-1340.
17. Naslund J, Thyberg J, Tjernberg L, et al. (1995) Characterization of stable complexes involving apolipoprotein E and the amyloid β-peptide in Alzheimer disease brain. Neuron 15: 219-228.
18. Wisniewski T, Lalowski M, Golabek A, Vogel T, Frangione B. (1995) Is Alzheimer's disease an apolipoprotein E amyloidosis? Lancet 345: 956-958.
19. Sanan D, Weisgraber K, Russell S, et al. (1994) Apolipoprotein E associates with β amyloid peptide of Alzheimer's disease to form novel monofibrils: Isoform apoE4 assodates more efficiently than ApoE3. J. Clin. Invest. 94: 860-869.
20. 1-antichymotrypsin and apolipoprotein E promote assembly of Alzheimer β-protein into filaments. Nature 372: 92-94.
21. Wisniewski T, Castano EM, Golabek A, Vogel T, Frangione B. (1994) Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro. Am. J. Pathol. 145: 1030-1035.
22. Castano EM, Prelli F, Wisniewski T, et al. (1995) Fibrillogenesis in Alzheimer's disease of amyloid β peptides and apolipoprotein E. Biochem. J. 306: 599-604.
23. Evans KC, Berger EP, Cho C-G, Weisgraber KH, Lansbury PT. (1995) Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: Implications for the pathogenesis and treatment of Alzheimer's disease. Proc. Natl. Acad. Sci. U.S.A. 92: 763-767.
24. LaDu M, Falduto M, Manelli A, Reardon C, Getz G, Frail D. (1994) Isoform-specific binding of apolipoprotein E to β-amyloid. J. Biol. Chem. 269: 23403-23406.
25. Smith JD, Melian A, Leff T, Breslow J. (1988) Expression of the human apolipoprotein E gene is regulated by multiple positive and negative elements. J. Biol. Chem. 263: 8300-8308.
26. Lehtimaki T, Pirttila T, Mehta PD, Wisniewski HM, Frey H, Nikkari, T. (1995) Apolipoprotein E (apoE) polymorphism and its influence on apoE concentrations in the cerebrospinal fluid in Finnish patients with Alzheimer's disease. Hum. Genet. 95: 39-42.
27. Rall SC, Weisgraber KH, Mahley RW. (1986) Isolation and characterization of apolipoprotein E. Methods Enzymol. 128: 273-287.
28. Goldgaber D, Lerman MI, McBride OW, Saffioti U, Gajdusek DC. (1987) Characterization and chromosomal localization of a cDNA encoding brain amyloid of Alzheimer's disease. Science 235: 877-880.
29. Citron M, Oltersdorf T, Haass C, et al. (1992) Mutation of the β-amyloid precursor protein in familial Alzheimer's disease causes increased β-protein production. Nature 360: 672-674.
30. Wisniewski T, Ghiso J, Frangione B. (1991) Peptides homologous to the amyloid protein of Alzheimer's disease containing a glutamine for glutamic acid substitution have accelerated amyloid fibril formation. Biochem. Biophys. Res. Commun. 179: 1247-1254.
31. 42 in the cerebrospinal fluid of patient's with Alzheimer's disease. Ann. Neurol. 38: 643-648.
32. Hyman BT, West HL, Rebeck GW, et al. (1995) Quantitative analysis of senile plaques in Alzheimer disease: Observation of log-normal size distribution and molecular epidemiology of differences associated with apolipoprotein E genotype and trisomy 21 (Down syndrome). Proc. Natl. Acad. Sci. U.S.A. 92: 3586-3590.
33. Poirier J. (1994) Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17: 525-530.
34. Gordon I, Grauer E, Genis I, Sehayek E, Michaelson DM. (1995) Memory deficits and cholinergic impairments in apolipoprotein E-deficient mice. Neurosci. Lett. 199: 1-4.
35. Gandy S, Stafstrom C, Turner B, et al. (1995) Aged apoE deficient mice: Abnormal learning & glial markers but no obvious neuropathology. Soc. Neurosci. Abstr. 21: 5.